June 12, 2024

Global number of monkeypox cases reported to WHO declines by 21 percent

On 24 May 2022, WHO Member States re-elected Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization. Dr Tedros was first elected in 2017. His re-election was confirmed during the 75th World Health Assembly in Geneva. He was the sole candidate. Today’s vote was the culmination of an election process that began in April 2021 when Member States were invited to submit proposals for candidates for the post of Director-General. The WHO Executive Board, meeting in January 2022, nominated Dr Tedros to stand for a second term. Dr Tedros’s new mandate officially commences on 16 August 2022. A Director-General can be re-appointed once, in accordance with World Health Assembly rules and procedures. https://www.who.int/news/item/24-05-2022-world-health-assembly-re-elects-dr-tedros-adhanom-ghebreyesus-to-second-term-as-who-director-general

The global number of monkeypox cases has declined by 21 percent in the past one week, the World Health Organization reported on Thursday, warning, however, that the number of cases reported in the Region of the Americas shows a continuing steep rise, confirming trends seen over the last several weeks.

Between August 15-21, the number of infections went from 7477 cases the previous week to 5907. This decrease may reflect early signs of a declining case count in the European region, which would need to be subsequently confirmed.

On August 8, the WHO convened a meeting of two WHO Collaborating Centres for orthopoxviruses and other experts in poxvirology and viral evolution to consider the naming of monkeypox virus (MPXV) variants, and later announced that the Congo Basin or Central African clade will be referred to as Clade I; the West African clade will be referred to as Clade II, with subclades IIa and IIb, the latter referring to the variant that is predominant in the multi-country outbreak.

WHO has also updated the interim guidance on vaccines and immunization for monkeypox. Updates include a clearer emphasis on the groups at risk of monkeypox for consideration for preventive vaccination, and updated terminology for pre- and post-exposure vaccination. To reduce confusion with the terms used in the management of HIV, the changes include using primary preventive (pre-exposure) vaccination (PPV) rather than pre-exposure prophylaxis (PrEP), and post-exposure vaccination (PEPV) rather than post exposure prophylaxis (PEP).

Notify of
Inline Feedbacks
View all comments